{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:09:56Z","timestamp":1749701396250,"version":"3.41.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,11]]},"DOI":"10.7759\/cureus.85759","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T11:27:46Z","timestamp":1749641266000},"source":"Crossref","is-referenced-by-count":0,"title":["Absence of KRAS Mutation as an Indicator of Pancreatic Metastasis Originating From Lung Cancer: A Case Report"],"prefix":"10.7759","author":[{"given":"Shuhei","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soshi","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Kabasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.06.027","article-title":"Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis","volume":"520","author":"Cai J","year":"2021","unstructured":"Cai J, Chen H, Lu M, et al.. Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis. Cancer Lett. 2021, 520:1-11. 10.1016\/j.canlet.2021.06.027","journal-title":"Cancer Lett"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2021.02.003","article-title":"KRAS mutation in pancreatic cancer","volume":"48","author":"Luo J","year":"2021","unstructured":"Luo J. KRAS mutation in pancreatic cancer. Semin Oncol. 2021, 48:10-18. 10.1053\/j.seminoncol.2021.02.003","journal-title":"Semin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2015.16.14.5619","article-title":"Pancreatic cancer: pathogenesis and diagnosis","volume":"16","author":"Goral V","year":"2015","unstructured":"Goral V. Pancreatic cancer: pathogenesis and diagnosis. Asian Pac J Cancer Prev. 2015, 16:5619-24. 10.7314\/apjcp.2015.16.14.5619","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052049","article-title":"Lung cancer-epidemiology, pathogenesis, treatment and molecular aspect (review of literature)","volume":"26","author":"Smolarz B","year":"2025","unstructured":"Smolarz B, \u0141ukasiewicz H, Samulak D, Piekarska E, Ko\u0142aci\u0144ski R, Romanowicz H. Lung cancer-epidemiology, pathogenesis, treatment and molecular aspect (review of literature). Int J Mol Sci. 2025, 26:2049. 10.3390\/ijms26052049","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(09)70065-8","article-title":"The role of surgery in the management of isolated metastases to the pancreas","volume":"10","author":"Reddy S","year":"2009","unstructured":"Reddy S, Wolfgang CL. The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol. 2009, 10:287-93. 10.1016\/s1470-2045(09)70065-8","journal-title":"Lancet Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2021.02.002","article-title":"KRAS G12C-mutant non-small cell lung cancer: biology, developmental therapeutics, and molecular testing","volume":"23","author":"Veluswamy R","year":"2021","unstructured":"Veluswamy R, Mack PC, Houldsworth J, Elkhouly E, Hirsch FR. KRAS G12C-mutant non-small cell lung cancer: biology, developmental therapeutics, and molecular testing. J Mol Diagn. 2021, 23:507-20. 10.1016\/j.jmoldx.2021.02.002","journal-title":"J Mol Diagn"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2022-001492","article-title":"Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer","volume":"10","author":"Batra U","year":"2023","unstructured":"Batra U, Biswas B, Prabhash K, Krishna MV. Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer. BMJ Open Respir Res. 2023, 10:e001492. 10.1136\/bmjresp-2022-001492","journal-title":"BMJ Open Respir Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/jgf2.612","article-title":"Pancreatic metastasis from lung adenocarcinoma","volume":"24","author":"Aoyama N","year":"2023","unstructured":"Aoyama N, Inokuma T, Nakanishi Y, Fukuda A. Pancreatic metastasis from lung adenocarcinoma. J Gen Fam Med. 2023, 24:192-3. 10.1002\/jgf2.612","journal-title":"J Gen Fam Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22461","article-title":"Distinct prognostic roles and heterogeneity of TTF1 copy number and TTF1 protein expression in non-small cell lung cancer","volume":"56","author":"Yoshimura K","year":"2017","unstructured":"Yoshimura K, Inoue Y, Mori K, et al.. Distinct prognostic roles and heterogeneity of TTF1 copy number and TTF1 protein expression in non-small cell lung cancer. Genes Chromosomes Cancer. 2017, 56:570-81. 10.1002\/gcc.22461","journal-title":"Genes Chromosomes Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC","volume":"382","author":"Ramalingam SS","year":"2020","unstructured":"Ramalingam SS, Vansteenkiste J, Planchard D, et al.. Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC. N Engl J Med. 2020, 382:41-50. 10.1056\/NEJMoa1913662","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2306434","article-title":"Osimertinib with or without chemotherapy in EGFR-mutated advanced NSCLC","volume":"389","author":"Planchard D","year":"2023","unstructured":"Planchard D, J\u00e4nne PA, Cheng Y, et al.. Osimertinib with or without chemotherapy in EGFR-mutated advanced NSCLC. N Engl J Med. 2023, 389:1935-48. 10.1056\/NEJMoa2306434","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-0417","article-title":"C-CAT: the national datacenter for cancer genomic medicine in Japan","volume":"12","author":"Kohno T","year":"2022","unstructured":"Kohno T, Kato M, Kohsaka S, et al.. C-CAT: the national datacenter for cancer genomic medicine in Japan. Cancer Discov. 2022, 12:2509-15. 10.1158\/2159-8290.CD-22-0417","journal-title":"Cancer Discov"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/367787-absence-of-kras-mutation-as-an-indicator-of-pancreatic-metastasis-originating-from-lung-cancer-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T11:27:46Z","timestamp":1749641266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/367787-absence-of-kras-mutation-as-an-indicator-of-pancreatic-metastasis-originating-from-lung-cancer-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.85759","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,11]]}}}